Gynecologic Oncology Reports (Dec 2024)
Dehydrated amniotic membrane patch for the treatment of an ocular event secondary to mirvetuximab soravtansine-gynx (MIRV) therapy
Abstract
No abstracts available.Keywords
Gynecologic Oncology Reports (Dec 2024)